SCHEMBL8068346

SCHEMBL8068346

Cc1cc(NS(=O)(=O)c2ccc(C#Cc3ccc(O)c(C(=O)O)c3)cc2)no1

nearest known ligand 0.66

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC7A11 Q9UPY5 2/20 0.66
CYP2C9 P11712 1/20 0.59
TSHR P16473 1/20 0.54
MAPK1 P28482 1/20 0.54
ALDH1A1 P00352 3/20 0.53
MAPT P10636 1/20 0.53
ADRA1A P35348 1/20 0.53
MEN1 O00255 3/20 0.50
KMT2A Q03164 3/20 0.50
PPIA P62937 1/20 0.50
HSP90AA1 P07900 1/20 0.50
HSP90AB1 P08238 1/20 0.50
AMY1A P0DUB6 1/20 0.49
HPGD P15428 1/20 0.49
HNF4A P41235 1/20 0.49
THRB P10828 1/20 0.48
ALOX12 P18054 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8058521 0.87 CYP2C9 (0.54) SLC7A11CYP2C9TSHRMAPK1ALDH1A1
SCHEMBL8069117 0.83 SLC7A11 (0.66) SLC7A11CYP2C9TSHRMAPK1ALDH1A1
SCHEMBL8069115 0.83 SLC7A11 (0.66) SLC7A11CYP2C9TSHRMAPK1ALDH1A1
SCHEMBL8068293 0.82 SLC7A11 (0.74) SLC7A11CYP2C9TSHRMAPK1ALDH1A1
SCHEMBL8067733 0.79 SLC7A11 (1.00) SLC7A11CYP2C9TSHRMAPK1ALDH1A1
SCHEMBL8068591 0.77 SLC7A11 (0.70) SLC7A11CYP2C9TSHRMAPK1ALDH1A1
Susalimod SCHEMBL1229340 0.77 SLC7A11 (1.00) SLC7A11CYP2C9TSHRMAPK1ALDH1A1
Susalimod SCHEMBL8069177 0.76 SLC7A11 (0.98) SLC7A11CYP2C9TSHRMAPK1ALDH1A1
SCHEMBL31469213 0.76 ALDH1A1 (0.73) CYP2C9TSHRMAPK1ALDH1A1MAPT
SCHEMBL1027519 0.73 TSHR (0.83) CYP2C9TSHRMAPK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0613468-B1 Substituted salicylic acids for the treatment of autoimmune diseases PHARMACIA & UPJOHN AB (SE) 2000-07-12 EP disclosed
CN-1042631-C Novel substituted salicylic acids KABI PHARMACIA AB (SE) 1999-03-24 CN disclosed
US-5556855-A TREATMENT OF AUTOIMMUNE DISEASES PHARMACIA AB (SE) 1996-09-17 US disclosed
US-5403930-A Chemical intermediate for drugs used in autoimmune diseases PHARMACIA AB (SE) 1995-04-04 US disclosed
CN-1088918-A The salicylic acid compounds of new replacement KABI PHARMACIA AB (SE) 1994-07-06 CN disclosed
US-5302718-A Used for treating autoimmune diseases KABI PHARMACIA AB (SE) 1994-04-12 US disclosed